98%
921
2 minutes
20
: Eosinophilic lung diseases (ELD) encompass disorders with an abnormally high number of polymorphonuclear eosinophils in the lungs. Presentation severity can range from low-grade fever and cough to life-threatening acute respiratory distress syndrome (ARDS). Due to the rarity of these conditions, no large sample studies have been performed to assess the characteristics of patients with pulmonary eosinophilia. : Patients admitted with a diagnosis of pulmonary eosinophilia between the years 2016 and 2020 were extracted from the largest inpatient US database, the Nationwide Inpatient Sample (NIS). Patients under the age of eighteen and those with diabetic ketoacidosis were excluded. Baseline demographic characteristics and medical comorbidities were evaluated for individuals admitted with pulmonary eosinophilia depending on intubation requirement. The primary outcomes included in-hospital mortality, intubation, and length of stay (LOS). : 3784 records were extracted, among which 384 patients required intubation. Patients who required intubation had higher rates of in-hospital mortality (23.9% vs. 1.2% < 0.0001%) and a significantly more prolonged hospital stay (19 days vs. 6 days < 0.001) compared to patients who did not need intubation. Factors associated with mortality in the intubated group included increasing age (OR: 1.022, 95% CI 1.002-1.042), duration of intubation superior to 96 h (OR: 2.705, 95% CI 1.235-5.927), and AKI (OR: 2.964, 95% CI 1.637-5.366). : Our findings suggest that ELD patients requiring intubation experience significantly higher rates of in-hospital mortality, acute kidney injury, deep venous thrombosis, and ARDS.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028457 | PMC |
http://dx.doi.org/10.3390/medicina61040556 | DOI Listing |
J Asthma Allergy
August 2025
Division of Respiratory Medicine, Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.
Allergic bronchopulmonary aspergillosis is characterized by hypersensitivity to spp. and often causes intractable asthma. Studies have been conducted on biologics administered to patients with allergic bronchopulmonary aspergillosis; however, treatment may not always be successful.
View Article and Find Full Text PDFJ Investig Med
August 2025
Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Preserved ratio impaired spirometry (PRISm) may be in the pre-stage of chronic obstructive pulmonary disease. However, little is known about peripheral eosinophils in PRISm. This study ultimately enrolled 7,301 community-dwelling participants aged 20 to 79 years without airflow obstruction.
View Article and Find Full Text PDFBMJ Case Rep
August 2025
Department of Respiratory Medicine, Northern Health and Social Care Trust, Antrim, Northern Ireland, UK.
We present a complex case highlighting the importance of a multi-disciplinary approach to reach a diagnosis of idiopathic hypereosinophilic syndrome. We describe an unexpected complication from high-dose steroids, inducing a tumour lysis-like syndrome. Very limited similar cases have been reported in non-malignant patients, leading us to question how we could alter our practice to anticipate patients who are at higher risk of tumour lysis syndrome (TLS) in our eosinophilic respiratory patient cohort by extrapolating on known TLS risk factors.
View Article and Find Full Text PDFSaudi J Med Med Sci
July 2025
Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction triggered by colonization of the airways that primarily affects immunocompetent individuals, particularly those with asthma. ABPA can often be misdiagnosed as severe asthma or non-resolving pneumonia, leading to delays in appropriate management. Early recognition of ABPA is crucial to prevent disease progression and unnecessary antibiotic use.
View Article and Find Full Text PDFPediatr Allergy Immunol Pulmonol
September 2025
Division of Pediatric Immunology and Allergy, Department of Pediatrics, Ankara Bilkent City Hospital, Ankara, Türkiye.
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a rare, potentially life-threatening hypersensitivity reaction characterized by skin rash, fever, eosinophilia, and multi-organ involvement. Although pulmonary complications are uncommon, they can significantly impact prognosis. Here, we present a 6-year-old male with antibiotic-induced DRESS syndrome complicated by pleural effusion and pneumonitis.
View Article and Find Full Text PDF